BRCA2 and neoplasm: In this study, we performed ddPCR to quantify the CNVs of BRCA1 and BRCA2 in the same exons as detected by MLPA, aiming to clarify the limitations in detecting DNA tumor heterogeneity, particularly in cases with ambiguous results.